Oramed Pharmaceuticals Stock Annual Yield

ORMP Stock  USD 2.92  0.10  3.55%   
Oramed Pharmaceuticals fundamentals help investors to digest information that contributes to Oramed Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Oramed Stock. The fundamental analysis module provides a way to measure Oramed Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oramed Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Oramed Annual Yield Analysis

Oramed Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
 2020 2021 2023 2024 (projected)
Fixed Asset Turnover2.91.491.721.63
Current Ratio14.2727.3424.6125.84

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Oramed Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Oramed Pharmaceuticals is extremely important. It helps to project a fair market value of Oramed Stock properly, considering its historical fundamentals such as Annual Yield. Since Oramed Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Oramed Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Oramed Pharmaceuticals' interrelated accounts and indicators.
0.77-0.850.830.570.830.8-0.560.660.810.790.350.76-0.090.420.090.550.570.640.510.810.510.640.370.5-0.59
0.77-0.910.990.230.961.0-0.780.910.90.990.560.92-0.040.020.260.810.830.830.230.970.190.890.590.75-0.73
-0.85-0.91-0.95-0.51-0.97-0.930.76-0.89-0.92-0.92-0.46-0.850.02-0.26-0.24-0.62-0.67-0.75-0.41-0.87-0.5-0.72-0.47-0.630.53
0.830.99-0.950.330.990.99-0.760.910.930.990.520.93-0.050.120.220.760.790.820.30.960.30.850.550.71-0.72
0.570.23-0.510.330.390.32-0.240.420.340.25-0.030.230.120.910.13-0.050.030.20.890.290.890.01-0.030.020.01
0.830.96-0.970.990.390.98-0.80.920.930.960.460.88-0.070.160.280.680.730.780.320.920.410.780.480.65-0.68
0.81.0-0.930.990.320.98-0.780.920.910.990.540.92-0.030.120.260.780.810.830.310.980.280.870.570.72-0.72
-0.56-0.780.76-0.76-0.24-0.8-0.78-0.8-0.75-0.73-0.45-0.50.020.03-0.77-0.56-0.64-0.72-0.19-0.69-0.37-0.62-0.53-0.670.33
0.660.91-0.890.910.420.920.92-0.80.850.890.40.790.040.190.430.60.670.730.340.850.420.690.430.58-0.58
0.810.9-0.920.930.340.930.91-0.750.850.910.450.84-0.150.130.260.710.730.790.260.850.370.790.550.67-0.65
0.790.99-0.920.990.250.960.99-0.730.890.910.560.96-0.050.060.170.810.820.820.240.970.20.890.580.74-0.75
0.350.56-0.460.52-0.030.460.54-0.450.40.450.560.530.32-0.260.120.420.380.32-0.110.55-0.090.490.320.46-0.25
0.760.92-0.850.930.230.880.92-0.50.790.840.960.53-0.040.09-0.120.780.770.730.240.940.10.860.510.65-0.78
-0.09-0.040.02-0.050.12-0.07-0.030.020.04-0.15-0.050.32-0.040.110.05-0.04-0.010.030.13-0.050.12-0.060.030.010.15
0.420.02-0.260.120.910.160.120.030.190.130.06-0.260.090.11-0.05-0.08-0.020.120.940.130.79-0.06-0.07-0.1-0.02
0.090.26-0.240.220.130.280.26-0.770.430.260.170.12-0.120.05-0.050.10.210.310.070.150.350.110.230.270.1
0.550.81-0.620.76-0.050.680.78-0.560.60.710.810.420.78-0.04-0.080.10.990.930.180.81-0.150.990.90.93-0.66
0.570.83-0.670.790.030.730.81-0.640.670.730.820.380.77-0.01-0.020.210.990.970.250.83-0.050.980.910.94-0.65
0.640.83-0.750.820.20.780.83-0.720.730.790.820.320.730.030.120.310.930.970.380.810.170.930.890.92-0.6
0.510.23-0.410.30.890.320.31-0.190.340.260.24-0.110.240.130.940.070.180.250.380.340.720.190.230.21-0.08
0.810.97-0.870.960.290.920.98-0.690.850.850.970.550.94-0.050.130.150.810.830.810.340.180.890.580.73-0.74
0.510.19-0.50.30.890.410.28-0.370.420.370.2-0.090.10.120.790.35-0.15-0.050.170.720.18-0.08-0.13-0.070.01
0.640.89-0.720.850.010.780.87-0.620.690.790.890.490.86-0.06-0.060.110.990.980.930.190.89-0.080.840.91-0.73
0.370.59-0.470.55-0.030.480.57-0.530.430.550.580.320.510.03-0.070.230.90.910.890.230.58-0.130.840.96-0.32
0.50.75-0.630.710.020.650.72-0.670.580.670.740.460.650.01-0.10.270.930.940.920.210.73-0.070.910.96-0.42
-0.59-0.730.53-0.720.01-0.68-0.720.33-0.58-0.65-0.75-0.25-0.780.15-0.020.1-0.66-0.65-0.6-0.08-0.740.01-0.73-0.32-0.42
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

In accordance with the recently published financial statements, Oramed Pharmaceuticals has an Annual Yield of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Oramed Annual Yield Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oramed Pharmaceuticals' direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oramed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oramed Pharmaceuticals by comparing valuation metrics of similar companies.
Oramed Pharmaceuticals is currently under evaluation in annual yield category among related companies.

Oramed Fundamentals

About Oramed Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Oramed Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oramed Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oramed Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Oramed Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock:
Check out Oramed Pharmaceuticals Piotroski F Score and Oramed Pharmaceuticals Altman Z Score analysis.
To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Oramed Stock analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Oramed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.14
Revenue Per Share
0.033
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.05)
Return On Equity
0.0324
The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.